These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 21327931)

  • 21. Clinical update on K-Ras targeted therapy in gastrointestinal cancers.
    Pant S; Hubbard J; Martinelli E; Bekaii-Saab T
    Crit Rev Oncol Hematol; 2018 Oct; 130():78-91. PubMed ID: 30196915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Personalized therapy of gastrointestinal cancers--possibilities and limitations].
    Wichert Gv; Adler G; Seufferlein T
    Dtsch Med Wochenschr; 2010 Aug; 135(34-35):1687-91. PubMed ID: 20721844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deciphering molecular determinants of chemotherapy in gastrointestinal malignancy using systems biology approaches.
    Lin LL; Huang HC; Juan HF;
    Drug Discov Today; 2014 Sep; 19(9):1402-9. PubMed ID: 24793142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic Advances in GI Malignancies--Fifth Annual Conference. 13-14 July 2007, Newport Beach, CA, USA.
    Alberts SR
    IDrugs; 2007 Oct; 10(10):693-5. PubMed ID: 17899484
    [No Abstract]   [Full Text] [Related]  

  • 25. Molecular Determinants of Statin-sensitivity in Cancer.
    Fatehi Hassanabad A; Wong JVS
    Am J Clin Oncol; 2020 Mar; 43(3):160-162. PubMed ID: 31842115
    [No Abstract]   [Full Text] [Related]  

  • 26. Lovastatin Inhibits RhoA to Suppress Canonical Wnt/β-Catenin Signaling and Alternative Wnt-YAP/TAZ Signaling in Colon Cancer.
    Xiao Y; Liu Q; Peng N; Li Y; Qiu D; Yang T; Kang R; Usmani A; Amadasu E; Borlongan CV; Yu G
    Cell Transplant; 2022; 31():9636897221075749. PubMed ID: 35168393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statin as a therapeutic agent in gastroenterological cancer.
    Uemura N; Hayashi H; Baba H
    World J Gastrointest Oncol; 2022 Jan; 14(1):110-123. PubMed ID: 35116106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statin and Cancer Mortality and Survival: An Umbrella Systematic Review and Meta-Analysis.
    Jeong GH; Lee KH; Kim JY; Eisenhut M; Kronbichler A; van der Vliet HJ; Shin JI; Gamerith G
    J Clin Med; 2020 Jan; 9(2):. PubMed ID: 31979352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lovastatin induces apoptosis of HepG-2 cells by activating ROS-dependent mitochondrial and ER stress pathways.
    Wang Y; Xie Y; Ma J; Gong R; Yan Z; Wang W; Wang Y; Xu B; Li X
    Int J Clin Exp Pathol; 2017; 10(12):11480-11488. PubMed ID: 31966503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lovastatin-mediated MCF-7 cancer cell death involves LKB1-AMPK-p38MAPK-p53-survivin signalling cascade.
    Huang SW; Chyuan IT; Shiue C; Yu MC; Hsu YF; Hsu MJ
    J Cell Mol Med; 2020 Jan; 24(2):1822-1836. PubMed ID: 31821701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug repurposing to overcome resistance to various therapies for colorectal cancer.
    Fong W; To KKW
    Cell Mol Life Sci; 2019 Sep; 76(17):3383-3406. PubMed ID: 31087119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statin uses and mortality in colorectal cancer patients: An updated systematic review and meta-analysis.
    Li Y; He X; Ding Y; Chen H; Sun L
    Cancer Med; 2019 Jun; 8(6):3305-3313. PubMed ID: 31069997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of survivin downregulation by simvastatin on the growth and invasion of salivary adenoid cystic carcinoma.
    Cai WY; Zhuang Y; Yan F; Li T; Song WT; Sun JH
    Mol Med Rep; 2018 Aug; 18(2):1939-1946. PubMed ID: 29956779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring the relationship between nonalcoholic fatty liver disease and pancreatic cancer by computed tomographic survey.
    Chang CF; Tseng YC; Huang HH; Shih YL; Hsieh TY; Lin HH
    Intern Emerg Med; 2018 Mar; 13(2):191-197. PubMed ID: 29235054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathway.
    Parrales A; Ranjan A; Iyer SV; Padhye S; Weir SJ; Roy A; Iwakuma T
    Nat Cell Biol; 2016 Nov; 18(11):1233-1243. PubMed ID: 27775703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lovastatin causes FaDu hypopharyngeal carcinoma cell death via AMPK-p63-survivin signaling cascade.
    Yen CS; Chen JC; Chang YF; Hsu YF; Chiu PT; Shiue C; Chuang YF; Ou G; Hsu MJ
    Sci Rep; 2016 Apr; 6():25082. PubMed ID: 27122225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting Oncogenic Mutant p53 for Cancer Therapy.
    Parrales A; Iwakuma T
    Front Oncol; 2015; 5():288. PubMed ID: 26732534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statin use and risk of liver cancer: an update meta-analysis.
    Shi M; Zheng H; Nie B; Gong W; Cui X
    BMJ Open; 2014 Sep; 4(9):e005399. PubMed ID: 25227628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aspirin may prevent cholangiocarcinoma: a case-control study from the United kingdom.
    Burr NE; Talboys RJ; Savva S; Clark A; Phillips M; Metcalfe M; Dennison A; Robinson R; Lewis MP; Rhodes M; Rushbrook S; Hart AR
    Dig Dis Sci; 2014 Jul; 59(7):1567-72. PubMed ID: 24535250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of onion flavonoids on colorectal cancer with hyperlipidemia: an in vivo study.
    He Y; Jin H; Gong W; Zhang C; Zhou A
    Onco Targets Ther; 2014; 7():101-10. PubMed ID: 24470761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.